A Bibliometric Analysis of the Most Cited Articles on Short Stature | [Journal of Pioneering Medical Sciences • 2025]

Author(s):

1. Jood Essam Alzohari: Collage of Medicine, University of Jeddah, Jeddah, Saudi Arabia

2. Abrar Mohamed Radhi: Bahrain Wenzhou Medical University, Wenzhou, China

3. Abrar Jamal Algethmi: Ibn Sina college, Jeddah, Saudi Arabia

4. Mayas Nasser Almuqati: University of Tabuk, Tabuk, Saudi Arabia

5. Rawan Hussain Alharbi: Maternity and Children Hospital, Qassim, Saudi Arabia

6. Abdulrahman: College of Medicine, King Saud University for Health Sciences, Riyadh, Saudi Arabia

7. Raneem Abdulrahman Aljawaied: College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

8. Ahmed J. Al Habeeb: Almaarefa University, Riyadh, Saudi Arabia

9. Refal Abdulrahman Alnughaymishi: Qassim University, Qassim, Saudi Arabia

10. Mohammed N. Aldosari: Assistance Professor,,Author Designation:,,

Abstract:

Short stature, defined as height significantly below the population average, can arise from various etiologies, including genetic mutations, hormonal imbalances and chronic illnesses. Despite increasing research, a comprehensive assessment of high-impact studies in this field remains lacking. This bibliometric analysis evaluates emerging research trends, methodological quality and the impact of the most-cited articles on short stature, highlighting strengths and identifying gaps in the literature. Methods: The 50 most relevant articles on short stature were organized in a bibliometric format and analyzed using R Studio with the packages “BiblioShiny,” “Bibliometrix” and “Meta.” The analysis included visualizing publication trends, identifying leading countries, authors and affiliations and calculating total citations. A thematic analysis assessed the frequency of key terms and research focus areas. Results: The analysis of the top 50 articles reveals that the USA dominates the publication landscape, contributing 58% of the articles, followed by the UK at 11%. Germany, Italy and the Netherlands contribute 5% each, while Switzerland, England and Japan provide 3% and Iran, Finland and France account for 2%. The studies utilize diverse methodologies, with genetic mutation research comprising 17 studies, alongside case-control studies, observational studies and systematic reviews. Genetic studies focusing on mutations in genes like PTPN11, FGFR3 and FGF23 are prevalent, elucidating conditions such as Noonan syndrome and Turner syndrome. Evidence levels vary, with many studies classified as Level 4, while comprehensive reviews and expert consensus papers are categorized as Level 1. Michael Holzer and Niklas Nielsen are the most productive authors, with citations of 1255 and 1231, respectively. The most prolific journal is “The American Journal of Medical Genetics Part A,” which published 17 relevant articles. Research volume has steadily increased over the past two decades, reflecting growing awareness of short stature as a significant public health issue. Conclusions: This analysis highlights significant contributions to short stature research, emphasizing the need for better translation of genetic findings into clinical outcomes. Future research should prioritize personalized treatments, advanced diagnostic tools and the psychosocial impacts on affected individuals.

Page(s): 53-68

DOI: 10.47310/jpms2025140809

Published: Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 8, Year: 2025

Keywords:

Short stature , Growth Disorder , Height Deficiency , Dwarfism

References:

[1] Plachy L. .2024 .. Editorial: Short Stature: Beyond Growth Hormone.” Frontiers in Endocrinology (Lausanne), 1403112 : 1403112.

[2] Sultan M. . .Etiology of Short Stature in Children. ” Journal of College of Physicians and Surgeons Pakistan, 18(2008) : 493-497.

[3] Sharma L.,Island (FL): StatPearls Publishing L. .2025 .. , : .

[4] Quitmann J.,July J. .2024 .. Short Stature: Practice Essentials, : .

[5] Tartaglia M. . .Mutations in PTPN11, Encoding the Protein Tyrosine Phosphatase SHP-2. Nature Genetics, 10(2001) : 465-468.

[6] Mundlos S. . .Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia. ” Cell, 8674(00) : 260-3.

[7] White K. .2000 .Autosomal Dominant Hypophosphataemic Rickets Is Associated with Mutations in FGF23.” Nature Genetics. , 26 : 345-348.

[8] Yachie A. . .Oxidative Stress Causes Enhanced Endothelial Cell Injury in Human Heme Oxygenase-1 Deficiency.. Journal of Clinical Investigation, 103(1999) : 129-135.

[9] Shiang R. . .Mutations in the Transmembrane Domain of FGFR3 Cause the Most Common Genetic Form of Dwarfism, Achondroplasia. Cell, 10(94) : 90302-6.

[10] Holick M.F. . .Resurrection of Vitamin D Deficiency and Rickets. ” Journal of Clinical Investigation, 116(2006) : 2062-2072.

[11] Cassidy S.B.,Prader-Willi Syndrome S.B. . .. , 10(2012) : 10-26.

[12] Woods K. .1996 .Intrauterine Growth Retardation and Postnatal Growth Failure Associated with Deletion of the Insulin-like Growth Factor I Gene. New England Journal of Medicine, 10(18) : 1363-1367.

[13] Varon R. . .Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome. ” Cell, 8674(00) : 81174-5.

[14] Hill I.D. . .Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. ” Journal of Pediatric Gastroenterology and Nutrition, 10(2005) : 200501000-19.

[15] Gelb .1996 .Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency.. Science, 10(5279) : 1236-1238.

[16] Galanello ,Beta-Thalassemia .2010 .. Orphanet Journal of Rare Diseases, 5(2010) : 1750.

[17] Rao E.,Syndrome Turner . .Pseudoautosomal Deletions Encompassing a Novel Homeobox Gene Cause Growth Failure in Idiopathic Short Stature. Nature Genetics, 16(1997) : 54-63.

[18] Prasad A.S. .1961 .Syndrome of Iron Deficiency Anemia. American Journal of Medicine, 10(61) : 90137-1.

[19] Zapf J. . .Radioimmunological Determination of Insulin-like Growth Factors I and II in Normal Subjects and in Patients with Growth Disorders and Extra Pancreatic Tumor Hypoglycemia. ” Journal of Clinical Investigation, 68(1981) : 1321-1330.

[20] Gravholt C.H. . .Clinical Practice Guidelines for the Care of Girls and Women with Turner Syndrome: Proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European Journal of Endocrinology, 177(2017) : G1-G70.

[21] de Onis F.,Branca A Global,Perspective A Global . .. Maternal and Child Nutrition, 10(2016) : 12-26.

[22] Hästbacka J. . .The Diastrophic Dysplasia Gene Encodes a Novel Sulfate Transporter: Positional Cloning by FineStructure Linkage Disequilibrium Mapping. ” Cell, 10(94) : 90281-x.

[23] Godowski P.J. .1989 .Characterization of the Human Growth Hormone Receptor Gene and Demonstration of a Partial Gene Deletion in Two Patients with Laron-Type Dwarfism. ” Proceedings of the National Academy of Sciences of the United States of America, 86(20) : 8083-8087.

[24] Baxter R.C.,J.L. Martin. R.C. . .Radioimmunoassay of Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein in Human Plasma. ” Journal of Clinical Investigation, 10(1986) : 1504-1512.

[25] Tartaglia M. . .PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity. American Journal of Human Genetics, 10(2002) : 1555-1563.

[26] Schubbert S. . .. Germline KRAS Mutations Cause Noonan Syndrome.” Nature Genetics, 38(2006) : 331-336.

[27] Roberts A.E. .2013 .. Noonan Syndrome.” Lancet, 6736(12) : 023-X.

[28] Pandit B. . .Gain-of-Function RAF1 Mutations Cause Noonan and LEOPARD Syndromes with Hypertrophic Cardiomyopathy. Nature Genetics, 10(2007) : 1007-1012.

[29] Embleton N.E. . .. Postnatal Malnutrition and Growth Retardation: An Inevitable Consequence of Current Recommendations in Preterm Infants?” Pediatrics, 10(2001) : 270-273.

[30] Karlberg J.,Albertsson-Wikland K.,Gestational-Age Infants . .“Growth in FullTerm Small-for-. Pediatric Research, 10(1995) : 00006450-739.

[31] Schipani E. .1995 .A Constitutively Active Mutant PTH-PTHrP Receptor in Jansen-Type Metaphyseal Chondrodysplasia. Science, 10(5207) : 98-100.

[32] Prendergast A.J.,Humphrey J.H. . .. The Stunting Syndrome in Developing Countries.” Paediatrics and International Child Health, 34(2014) : 0000000158-265.

[33] Clayton P.E. . .Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. ” Journal of Clinical Endocrinology and Metabolism, 10(2007) : 2017-810.

[34] Tavormina P.L. . .Thanatophoric Dysplasia (Types I and II) Caused by Distinct Mutations in Fibroblast Growth Factor Receptor 3. , 9(1995) : 321-328.

[35] Cohen P. .2008 .Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society. the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology Workshop.” Journal of Clinical Endocrinology and Metabolism, 0509(11) : 4210-4217.

[36] Spiliotis B.E. .1984 ."Growth Hormone Neurosecretory Dysfunction. A Treatable Cause of Short Stature." JAMA, 251(17) : 2223-2230.

[37] Silventoinen K. . ."Heritability of Adult Body Height: A Comparative Study of Twin Cohorts in Eight Countries.". Twin Research, 6(2003) : 399-408.

[38] Abuzzahab M.J. .2003 ."IGF-I Receptor Mutations Resulting in Intrauterine and Postnatal Growth Retardation.". New England Journal of Medicine, 10(23) : 2211-2222.

[39] Tartaglia M. . ."Gain-of-Function SOS1 Mutations Cause a Distinctive Form of Noonan Syndrome.". Nature Genetics, 10(2006) : 75-79.

[40] Horwitz E.M. " . .Clinical Responses to Bone Marrow Transplantation in Children with Severe Osteogenesis Imperfecta.". Blood, 5(2001) : 1227-1231.

[41] Grimberg A.,Insulin-Like Growth Factor-I Deficiency Primary . ." Hormone Research in Paediatrics. , 10(2016) : 361-397.

[42] Briggs M.D. . ."Pseudoachondroplasia and Multiple Epiphyseal Dysplasia due to Mutations in the Cartilage Oligomeric Matrix Protein Gene.". Nature Genetics, 10(1995) : 330-336.

[43] van der Eerden B.C.J. . ."Systemic and Local Regulation of the Growth Plate.". Endocrine Reviews, 0033(2003) : 782-801.

[44] Novelli G. . ."Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C." American Journal of Human Genetics. , 10(2002) : 426-431.

[45] Romano A.A. . ."Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines.". Pediatrics, 3207(2010) : 746-759.

[46] Spence J.E. .2024 ."Uniparental Disomy as a Mechanism for Human Genetic Disease.". Accessed December, 42(1988) : 217.

[47] Rosenfeld R.G. . ."Growth Hormone (GH) Insensitivity due to Primary GH Receptor Deficiency.". Endocrine Reviews, 10(1994) : 369-390.

[48] Baumann G.,Proteins Binding . ."Growth Hormone Heterogeneity: Genes, Isohormones. " Endocrine Reviews, 10(1991) : 424-449.

[49] Hennekam R.C.M. .2006 ." American Journal of Medical Genetics A. , 31346(23) : 2603-2624.

[50] Niikawa N.,Ears Protruding . ."Kabuki Make-Up Syndrome: A Syndrome of Mental Retardation, Unusual Facies, Large. " Journal of Pediatrics, 3476(81) : 80255-7.

[51] Gicquel C. . ."Epimutation of the Telomeric Imprinting Center Region on Chromosome 11p15 in Silver-Russell Syndrome.". Nature Genetics, 10(2005) : 1003-1007.

[52] Angulo M.,Findings Endocrine .2015 ."Prader-Willi Syndrome: A Review of Clinical, Genetic. " Journal of Endocrinological Investigation, 10(12) : 1249-1263.

[53] Horton W.A. .2007 .. "Achondroplasia." Lancet, 6736(07) : 61090-3.

[54] Hofman P.L. . ."Insulin Resistance in Short Children with Intrauterine Growth Retardation.". Journal of Clinical Endocrinology and Metabolism, 82(1997) : 402-406.

[55] Lassarre C. . .Serum Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in the Human Fetus: Relationships with Growth in Normal Subjects and in Subjects with Intrauterine Growth Retardation. Pediatric Research, 10(1991) : 00006450-225.

[56] Razzaque M. . .Germline Gain-of-Function Mutations in RAF1 Cause Noonan Syndrome. Nature Genetics, 39(2007) : 1013-1017.

[57] Saenger P. . .Small for Gestational Age: Short Stature and Beyond. Endocrine Reviews, 0039(2007) : 219-251.

[58] Ahn J. . .Cloning of the Putative Tumour Suppressor Gene for Hereditary Multiple Exostoses (EXT1).” Nature Genetics. , 11(1995) : 137-143.

[59] El-Hattab A.W. .2015 .. MELAS Syndrome: Clinical Manifestations, Pathogenesis, and Treatment Options.” Molecular Genetics and Metabolism, 06(1-2) : 4-12.

[60] Sandstead H.H. . .Human Zinc Deficiency, Endocrine Manifestations. American Journal of Clinical Nutrition, 10(1967) : 422-442.

[61] Martorell R. . .Reversibility of Stunting: Epidemiological Findings in Children from Developing Countries. European Journal of Clinical Nutrition, 1(1994) : S45-S57.

[62] Patten J.L. .1990 .Mutation in the Gene Encoding the Stimulatory G Protein of Adenylate Cyclase in Albright's Hereditary Osteodystrophy. ” New England Journal of Medicine, 322(20) : 1412-1419.

[63] Prasad A.S. .1963 .. Archives of Internal Medicine, 036(1963) : 407.

[64] Multicenter Growth Reference WHO .2006 .. ” Acta Paediatrica Supplement, 10(450) : 2227-85.

[65] Wit J.M.,Evaluation Diagnostic .2007 .. Growth Hormone & IGF Research, 11 : 89-110.

[66] Sweileh W.M. .2020 .Bibliometric Analysis of Peer-Reviewed Literature on Climate Change and Human Health with an Emphasis on Infectious Diseases. Global Health, 10(2020) : 44.

[67] Nations United .2024 .. Accessed December 15, : .

[68] .2024 .. Accessed December 13, : .

[69] . .. int/child-adolescent-health/adolescent -health/adolescent-health.html., : .

[70] Jafari Z.A.M. .2018 .Short Stature in Children: A Review of Literature. Egyptian Journal of Hospital Medicine, 70(12) : 2058-2066.

Citations

Downloads

Views